Biotech Values

[mcbio]

Re: Ablynx/competition

I think Micromet (MITI) is one to keep an eye on in the antibody space. However, I'd like to see them sign a nice partnership and get a nice chunk of cash upfront as their finances are not exactly in order. They expected to sign two partnerships in 2009 and did just ink Bayer (http://finance.yahoo.com/news/Micromet-Enters-Into-prnews-14027982.html ) to a deal worth about $6 million with possibly more downstream.

There have been a lot of articles on Seeking Alpha, for better or worse (lol), during the past year about the company. See, e.g., http://seekingalpha.com/article/63379-micromet-biting-cancer and http://seekingalpha.com/article/63887-micromet-biting-cancer-part-ii.